Keyphrases
Mycobacterium Tuberculosis (M. tb)
100%
Tuberculosis Vaccine
100%
Bacillus Calmette-Guérin Vaccine
75%
Cryptococcal Antigen
50%
Bacillus Calmette-Guérin
50%
CD4+ T
50%
Cell Response
50%
Next-generation Vaccines
50%
Immunization
50%
Tuberculosis
50%
Immunodominant Antigen
25%
Active Tuberculosis
25%
Global Burden of Disease
25%
Improved Vaccines
25%
Adaptive Immune Response
25%
Achilles Heel
25%
Structural Proteins
25%
Mycobacterium Bovis
25%
Effective Compounds
25%
Protein Antigen
25%
Marginal Effects
25%
Unprecedented Level
25%
Vaccination
25%
Live Attenuated
25%
Protective Immunity
25%
Infectious Diseases
25%
Drug Therapy
25%
Knowledge Gaps
25%
Prime-boost
25%
Vaccine Design
25%
Latent Tuberculosis
25%
T Cell Response
25%
Immunodominant
25%
Secreted Proteins
25%
Mycobacterium Tuberculosis Infection
25%
Target Antigen
25%
Immunology and Microbiology
Mycobacterium Tuberculosis
100%
Mycobacterium Bovis BCG
80%
BCG Vaccine
60%
T-Helper Cell
40%
Infection
40%
Drug Therapy
20%
Disease Burden
20%
T Cell
20%
Adaptive Immune System
20%
Structural Protein
20%
Infectious Disease
20%
Pharmacology, Toxicology and Pharmaceutical Science
Mycobacterium Bovis BCG
100%
Mycobacterium Tuberculosis
100%
BCG Vaccine
75%
Infection
25%
Pharmacotherapy
25%
Structural Protein
25%
Latent Tuberculosis
25%
Global Disease Burden
25%